AbbVie has agreed to buy Capstan Therapeutics for up to $2.1 billion, expanding its pipeline with a potential first-in-class treatment for autoimmune diseases as well as adding a novel RNA delivery ...

Yesterday, the biotechnology company Capstan Therapeutics launched with $165 million in seed and Series A funding for it to build on its foundational insights into precision in vivo engineering ...

Eligible New Jersey renters seeking rental property tax relief in NJ can now apply for 2025 ANCHOR rebates, and while some are still asking "Where's my refund" when it comes to 2024 ANCHOR benefits, ...

C&C Marine and Repair, Belle Chasse, La., has delivered the M/V Al Sloss to Canal Barge Company, completing the first vessel in a four-boat newbuild series currently under construction for the New ...

When trying to pick out quality glass cookware for your kitchen, brands like Pyrex and Anchor Hocking may be top of mind. Both brands have made a name for themselves in the durable glass cookware ...

Join us as we uncover the hidden anchor room aboard naval warships - the cramped, rarely seen space where chain, capstan, and maintenance gear are stowed and managed. We explain how anchors are ...

Sept 23 (Reuters) - Biotech company Arcturus Therapeutics (ARCT.O), opens new tab sued AbbVie (ABBV.N), opens new tab in California federal court on Tuesday for allegedly stealing trade secrets ...

In today’s high-stakes maritime environment, operational efficiency, regulatory compliance, and crew safety are more than just checkboxes—they’re mission-critical. That’s where ABS Wavesight Nautical ...

NORTH CHICAGO - AbbVie (NYSE:ABBV), a $365 billion market cap biotechnology giant with over $58 billion in annual revenue, announced Tuesday it has completed its acquisition of Capstan Therapeutics, ...

AbbVie will pay US$2.1 billion to acquire Capstan Therapeutics and its in vivo CAR T technology, which uses mRNA-loaded lipid nanoparticles (LNPs) to reprogramme immune cells. Capstan’s lead asset is ...

Capstan Therapeutics — a biotechnology company pioneered by Penn researchers — was acquired by AbbVie in $2.1 billion deal. Capstan, which specializes in CAR-T therapies for autoimmune disorders, ...

AbbVie has announced that it will be expanding its immunology capabilities by acquiring Capstan Therapeutics for up to $2.1bn. The agreement will give AbbVie access to Capstan’s lead CAR-T therapy ...